SMNRW Semnur Pharmaceuticals, Inc.
Fundamentals / CIK 0001913577 / USDSemnur Pharmaceuticals, Inc. reported $2.01M in total assets and a net loss of $18.71M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SMNRW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$18.54M Operating profit
-
Net Income FY 2025-$18.71M GAAP bottom line
-
Diluted EPS FY 2025-$0.08 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$54K Total debt: --
Annual revenue and net income
4 fiscal years (2022 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Research & Development | $2.55M | $1.71M | -- | -- |
| Total Operating Expenses | $160.4M | $4.69M | -- | -- |
| Operating Income | -$160.4M | -$4.69M | -$3.17M | -- |
| EBITDA | -$160.4M | -$4.69M | -- | -- |
| Interest Income | -- | $1.58M | $3.84M | $1.22M |
| Interest Expense | -- | $96K | $37K | -- |
| Income Before Tax | $0 | $0 | -- | -- |
| Income Tax Expense | $0 | $0 | -- | -- |
| Net Income | -$160.4M | -$4.69M | $633K | -$419K |
| Basic EPS | -$0.78 | -$0.02 | -- | -- |
| Diluted EPS | -$0.78 | -$0.02 | -- | -- |
| Basic Shares Outstanding | 204.8M | 200.0M | -- | -- |
| Diluted Shares Outstanding | 204.8M | 200.0M | -- | -- |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $1.44M | $1.25M | $1.27M | $714K | $1.14M | $502K | $187K | -- |
| Total Operating Expenses | $3.58M | $4.22M | $4.58M | $6.16M | $152.6M | $999K | $665K | -- |
| Operating Income | -$3.58M | -$4.22M | -$4.58M | -$6.16M | -$152.6M | -$999K | -$665K | -$776K |
| EBITDA | -$3.58M | -$4.22M | -$4.58M | -$6.16M | -$152.6M | -$999K | -$665K | -- |
| Interest Income | -- | -- | -- | -- | -- | $18K | $79K | $87K |
| Interest Expense | $56K | $123K | -- | -- | $0 | $28K | $27K | $27K |
| Net Income | -$3.63M | -$4.35M | -$4.58M | -$6.16M | -$152.6M | -$999K | -$665K | -$167K |
| Basic EPS | -$0.02 | -$0.02 | -$0.02 | -- | -$0.76 | -$0.01 | -$0.01 | -- |
| Diluted EPS | -$0.02 | -$0.02 | -$0.02 | -- | -$0.76 | -$0.01 | -$0.01 | -- |
| Basic Shares Outstanding | 224.2M | 230.2M | 230.2M | -- | 201.7M | 200.0M | 200.0M | -- |
| Diluted Shares Outstanding | 224.2M | 230.2M | 230.2M | -- | 201.7M | 200.0M | 200.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $20K | $12K | $204K | $820K |
| Cash & Short-Term Investments | $20K | $12K | $204K | $820K |
| Other Current Assets | $0 | $5.98M | -- | -- |
| Total Current Assets | $596K | $6.00M | $209K | $908K |
| Property, Plant & Equipment, Net | $750K | $689K | -- | -- |
| Total Non-Current Assets | $750K | $689K | $50.48M | $85.37M |
| Total Assets | $1.35M | $6.68M | $50.69M | $86.28M |
| Accounts Payable | $5.91M | $0 | -- | -- |
| Total Current Liabilities | $10.17M | $35K | $5.60M | $1.29M |
| Total Non-Current Liabilities | $11.93M | $49.43M | $2.89M | $2.89M |
| Total Liabilities | $22.10M | $49.47M | $8.49M | $4.18M |
| Common Stock | $23K | $20K | -- | $51 |
| Retained Earnings | -$275.8M | -$115.4M | -$8.28M | -$3.27M |
| Total Stockholders' Equity | -$20.75M | -$42.78M | -$38.09M | -$3.27M |
| Total Equity | -$20.75M | -$42.78M | -$38.09M | -$3.27M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $54K | $39K | $103K | $20K | $85K | -- | $2.7K | $12K |
| Cash & Short-Term Investments | $54K | $39K | $103K | $20K | $85K | -- | $2.7K | $12K |
| Other Current Assets | -- | $51K | -- | $0 | $0 | -- | -- | $5.98M |
| Total Current Assets | $1.26M | $1.19M | $1.22M | $596K | $85K | $14K | $2.7K | $6.00M |
| Property, Plant & Equipment, Net | $750K | $750K | $750K | $750K | $689K | -- | -- | $689K |
| Total Non-Current Assets | $750K | $750K | $750K | $750K | $689K | $548K | $9.15M | $689K |
| Total Assets | $2.01M | $1.94M | $1.97M | $1.35M | $774K | $562K | $9.15M | $6.68M |
| Accounts Payable | $7.11M | $6.92M | $6.42M | $5.91M | $4.29M | -- | -- | $0 |
| Total Current Liabilities | $11.28M | $10.67M | $10.38M | $10.17M | $10.03M | $8.27M | $7.85M | $35K |
| Total Non-Current Liabilities | $24.04M | $20.94M | $16.91M | $11.93M | $5.33M | $2.89M | $2.89M | $49.43M |
| Total Liabilities | $35.31M | $31.62M | $27.30M | $22.10M | $15.37M | $11.16M | $10.74M | $49.47M |
| Common Stock | $23K | $23K | $23K | $23K | $23K | -- | -- | $20K |
| Retained Earnings | -$288.4M | -$284.7M | -$280.4M | -$275.8M | -$269.6M | -$11.14M | -$10.74M | -$115.4M |
| Total Stockholders' Equity | -$33.31M | -$29.67M | -$25.33M | -$20.75M | -$14.59M | -$44.45M | -$43.45M | -$42.78M |
| Total Equity | -$33.31M | -$29.67M | -$25.33M | -$20.75M | -$14.59M | -$44.45M | -$43.45M | -$42.78M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Net Income | -$160.4M | -$4.69M | $633K | -$419K |
| Depreciation & Amortization | $0 | $0 | -- | -- |
| Stock-Based Compensation | $142.4M | $660K | -- | -- |
| Change in Payables | $2.15M | $0 | -- | -- |
| Operating Cash Flow | -$5.87M | -$4.89M | -$633K | -$426K |
| Purchases of Investments | -- | -- | -$825K | -$84.15M |
| Investing Cash Flow | -- | $43.43M | $39.71M | -$84.15M |
| Share Repurchases | -- | -$43.43M | -$40.54M | -- |
| Financing Cash Flow | $5.88M | $4.89M | -$39.69M | $85.40M |
| Net Change in Cash | $8.0K | $0 | -$615K | $820K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.63M | -$4.35M | -$4.58M | -$6.16M | -$152.6M | -$999K | -$665K | -$167K |
| Depreciation & Amortization | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| Stock-Based Compensation | $855K | $1.29M | $1.48M | $2.03M | $140.2M | $119K | $92K | -- |
| Change in Payables | $189K | $495K | $511K | $1.62M | $521K | $0 | $0 | -- |
| Operating Cash Flow | -$2.22M | -$2.14M | -$2.67M | -$3.60M | -$2.13M | $268K | -$399K | -$1.41M |
| Financing Cash Flow | $2.24M | $2.07M | $2.75M | $3.54M | $2.16M | -$220K | $394K | $1.41M |
| Net Change in Cash | $15K | -$64K | $83K | -$65K | $30K | $48K | -$5.0K | -$1.0K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Return on Assets (ROA) | -11918.0% | -70.2% | 1.2% | -0.5% |
| Current Ratio | 0.06x | 171.29x | 0.04x | 0.70x |
| Quick Ratio | 0.00x | 0.34x | 0.04x | 0.63x |
| Net Income Growth (YoY) | -- | -841.5% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -931.5% | -8629.7% | -8345.7% | -11918.0% | -19951.6% | -556.4% | -35.4% | -61.1% |
| Current Ratio | 0.11x | 0.11x | 0.12x | 0.06x | 0.01x | 0.00x | 0.00x | 171.29x |
| Quick Ratio | 0.00x | 0.00x | 0.01x | 0.00x | 0.01x | -- | 0.00x | 0.34x |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -126.5% |
| Operating Cash Flow Growth (YoY) | -- | -897.8% | -- | -- | -- | -- | -- | -- |